Metastatic Triple Negative Breast Cancer
Pediatric Glioma
These trials are in various stages of completion. You may want to enter one, or you may just want to follow the results or learn more.
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer
NCT05318469 · RECRUITING · PHASE1/PHASE2 · posted 2022-04-08 · updated 2026-08-05
https://clinicaltrials.gov/study/NCT05318469
Last Update Posted 2026-08-05, Study Start (Actual) 2023-10-13, Primary Completion (Estimated) 2026-10
This phase II trial studies the side effects and best dose of ivermectin in combination with balstilimab or pembrolizumab and to see how well they work in shrinking tumors in patients with triple negative breast cancer that has spread to other places in the body (metastatic).
A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas
NCT01837862 · ACTIVE_NOT_RECRUITING · PHASE1/PHASE2 · posted 2013-04-23 · updated 2026-08-06, Study Completion (Estimated) 2027-12
https://clinicaltrials.gov/study/NCT01837862
[Active, not recruiting; No longer looking for participants]
This is a study to determine the safety and efficacy of the drug mebendazole when used in combination with standard chemotherapy drugs for the treatment of pediatric brain tumors.
Wonderful! So good to see such transparency and to be able to follow the progress!